The United States Preventive Services Task Force (USPSTF) recently released “Hormone Therapy for the Primary Prevention of Chronic Conditions: A Systematic Review to Update the US Preventive Services Task Force Recommendations.”
There is also a special version for consumers.
The Task Force conclusions are consistent with the NAMS 2012 Hormone Therapy Position Statement, which is also accompanied by a patient handout.
An interesting component of this USPSTF publication is a section discussing the public comments that were made during the time the draft was posted online earlier in the year. The Task Force points out that it is not addressing the use of hormone therapy for treatment of menopausal symptoms. These features make the report very consistent with our HT Position Statement and allow room for our Experts Do Agree solidarity statement regarding treatment of menopausal symptoms, also with patient handout.
Type the code from the image
We strive to bring you the most recent and interesting information about various aspect of menopause and midlife health. We accept no advertising for our website. We want you to have accurate, unbiased, evidence-based information.
This site complies
with the HONcode
information: verify here.